Anumigilimab (CSL-324) is a humanized IgG2a monoclonal antibody (mAb) targeting the human granulocyte colony-stimulating factor (G-CSF) receptor, utilized to elevate neutrophil counts at inflammation sites [1] [2].
CAS Number:
[2416593-08-1]
* VAT and and shipping costs not included. Errors and price changes excepted